Indeed, one of the vital pieces of evidence is ERK saturation mutagenesis by Brenan et al., as they observed in human melanoma cell line model with BRAFV600E, expression of wild-type ERK and activating ERK variants could be tolerated only in the presence of ERK pathway inhibitors90. This evidence concerns the gene MAPK1 and melanoma.